Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Surufatinib Capsules

Approval Number

国药准字H20200017

Company和记黄埔医药（上海）有限公司

Registration Date

December 29, 2020

Drug Information

Generic Name

索凡替尼胶囊

Trade Name

苏泰达/SULANDA

Brand Name

苏泰达

Dosage Form

胶囊剂

Strength

50mg

Drug Type

化学药品

Registration Date

December 29, 2020

Company Information

Applicant Company

Company Name和记黄埔医药（上海）有限公司

Company Address

中国（上海）自由贸易试验区蔡伦路720弄4号

Manufacturing Company

Company Name和记黄埔医药（苏州）有限公司

Company Address

苏州工业园区东平街188号C32栋

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

索凡替尼胶囊 - NMPA 批准文号 | MedPath